154 related articles for article (PubMed ID: 11070550)
1. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
[TBL] [Abstract][Full Text] [Related]
2. Tracking the distribution of "ecstasy" tablets by Raman composition profiling: a large scale feasibility study.
Bell SE; Barrett LJ; Burns DT; Dennis AC; Speers SJ
Analyst; 2003 Nov; 128(11):1331-5. PubMed ID: 14700225
[TBL] [Abstract][Full Text] [Related]
3. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
[TBL] [Abstract][Full Text] [Related]
4. Rapid analysis of ecstasy and related phenethylamines in seized tablets by Raman spectroscopy.
Bell SE; Burns DT; Dennis AC; Speers JS
Analyst; 2000 Mar; 125(3):541-4. PubMed ID: 10829348
[TBL] [Abstract][Full Text] [Related]
5. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
[TBL] [Abstract][Full Text] [Related]
6. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
7. Screening tablets for DOB using surface-enhanced Raman spectroscopy.
Bell SE; Fido LA; Sirimuthu NM; Speers SJ; Peters KL; Cosbey SH
J Forensic Sci; 2007 Sep; 52(5):1063-7. PubMed ID: 17680788
[TBL] [Abstract][Full Text] [Related]
8. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
Tanner-Smith EE
Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
[TBL] [Abstract][Full Text] [Related]
10. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
11. Impurity profiling of seized MDMA tablets by capillary gas chromatography.
Palhol F; Boyer S; Naulet N; Chabrillat M
Anal Bioanal Chem; 2002 Sep; 374(2):274-81. PubMed ID: 12324849
[TBL] [Abstract][Full Text] [Related]
12. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Parrott AC
Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
[TBL] [Abstract][Full Text] [Related]
13. Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
Sherlock K; Wolff K; Hay AW; Conner M
J Accid Emerg Med; 1999 May; 16(3):194-7. PubMed ID: 10353046
[TBL] [Abstract][Full Text] [Related]
14. A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets.
Moreno D; Díaz de Greñu B; García B; Ibeas S; Torroba T
Chem Commun (Camb); 2012 Mar; 48(24):2994-6. PubMed ID: 22314849
[TBL] [Abstract][Full Text] [Related]
15. Is online information on ecstasy tablet content safe?
Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
[TBL] [Abstract][Full Text] [Related]
16. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
Carter JF; Titterton aE; Murray M; Sleeman R
Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919
[TBL] [Abstract][Full Text] [Related]
17. The content of ecstasy tablets: implications for the study of their long-term effects.
Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
[TBL] [Abstract][Full Text] [Related]
18. Development of a Library Search-Based Screening System for 3,4-Methylenedioxymethamphetamine in Ecstasy Tablets Using a Portable Near-Infrared Spectrometer.
Tsujikawa K; Yamamuro T; Kuwayama K; Kanamori T; Iwata YT; Miyamoto K; Kasuya F; Inoue H
J Forensic Sci; 2016 Sep; 61(5):1208-14. PubMed ID: 27362667
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine quantification via benchtop
Frinculescu A; Maier AFG; Shine T; Ramsey J; Araneda JF; Riegel SD; Frascione N; Abbate V
J Pharm Biomed Anal; 2022 May; 214():114728. PubMed ID: 35349940
[TBL] [Abstract][Full Text] [Related]
20. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
